Fien De Boever

Journal Article
A1
open access

Safety and immunogenicity of an adjuvanted clostridioides difficile vaccine candidate in healthy adults : a randomized placebo-controlled phase 1 study

Isabel Leroux-Roels (UGent) , Azhar Alhatemi (UGent) , Magalie Caubet, Fien De Boever (UGent) , Bertrand de Wergifosse, Mohamed El Idrissi, Guilherme S Ferreira, Bart Jacobs (UGent) , Axel Lambert, Sandra Morel, et al.

(2025) JOURNAL OF INFECTIOUS DISEASES. 231(3). p.e511-e520

Add to list

Journal Article
A1
open access

Evaluation of safety, immunogenicity and cross-reactive immunity of OVX836, a nucleoprotein-based universal influenza vaccine, in older adults

Bart Jacobs, Isabel Leroux-Roels (UGent) , Jacques Bruhwyler, Nicola Groth, Gwenn Waerlop (UGent) , Yorick Janssens (UGent) , Jessika Tourneur, Fien De Boever (UGent) , Azhar Alhatemi (UGent) , Philippe Moris, et al.

(2024) VACCINES. 12(12).

Add to list

Journal Article
A1
open access

Safety and immunogenicity of a carbohydrate fatty acid monosulphate ester adjuvant combined with a low-dose quadrivalent split-virion inactivated influenza vaccine : a randomised, observer-blind, active-controlled, first-in-human, phase 1 study

Valentino D'Onofrio (UGent) , Sharon Porrez (UGent) , Bart Jacobs (UGent) , Azhar Alhatemi (UGent) , Fien De Boever (UGent) , Gwenn Waerlop (UGent) , Els Michels, Francesca Vanni, Alessandro Manenti, Geert Leroux-Roels (UGent) , et al.

(2024) VACCINES. 12(9).

Add to list

Journal Article
A1
open access

Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults : a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial

Isabel Leroux-Roels (UGent) , Chittappen Kandiyil Prajeeth, Amare Aregay, Niranjana Nair, Guus F Rimmelzwaan, Albert D M E Osterhaus, Simone Kardinahl, Sabrina Pelz, Stephan Bauer, Valentino D'Onofrio (UGent) , et al.

(2024) LANCET INFECTIOUS DISEASES. 24(11). p.1245-1253

Add to list

Journal Article
A1
open access

Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate : a randomised, double-blind, placebo-controlled, phase 2a trial

Isabel Leroux-Roels (UGent) , Paul Willems, Gwenn Waerlop (UGent) , Yorick Janssens (UGent) , Jessika Tourneur, Fien De Boever (UGent) , Jacques Bruhwyler, Azhar Alhatemi (UGent) , Bart Jacobs (UGent) , Florence Nicolas, et al.

(2023) LANCET INFECTIOUS DISEASES. 23(12). p.1360-1369

Add to list

Journal Article
A1
open access

Randomized, double-blind, reference-controlled, phase 2a study evaluating the immunogenicity and safety of OVX836, a nucleoprotein-based influenza vaccine

Isabel Leroux-Roels (UGent) , Gwenn Waerlop (UGent) , Jessika Tourneur, Fien De Boever (UGent) , Catherine Maes (UGent) , Jacques Bruhwyler, Delphine Guyon-Gellin, Philippe Moris, Judith Del Campo, Paul Willems, et al.

(2022) FRONTIERS IN IMMUNOLOGY. 13.

Add to list

A randomized, observer-blind phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women

Geert Leroux-Roels (UGent) , Cathy Maes, Julie Willekens (UGent) , Fien De Boever (UGent) , Richard de Rooij, Leah Martell, Lisa Bedell, Frederick Wittke, Karen Slobod and Peter Dull

(2016) VACCINE. 34(15). p.1786-1791

Add to list

Journal Article
A1
open access

Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults : a phase I/II randomized clinical study

Geert Leroux-Roels (UGent) , Cathy Maes, Fien De Boever (UGent) , Magali Traskine, Jens U Rüggeberg and Dorota Borys

(2014) VACCINE. 32(50). p.6838-6846

Add to list

Improved CD4⁺ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial

Isabel Leroux-Roels (UGent) , Sheron Forgus, Fien De Boever (UGent) , Frédéric Clement (UGent) , Marie-Ange Demoitié, Pascal Mettens, Philippe Moris, Edouard Ledent, Geert Leroux-Roels (UGent) and Opokua Ofori-Anyinam

(2013) VACCINE. 31(17). p.2196-2206

Add to list

Journal Article
A1
open access

Randomized trial of the immunogenicity and safety of the hepatitis B vaccine given in an accelerated schedule coadministered with the human papillomavirus type 16/18AS04-adjuvanted cervical cancer vaccine

Geert Leroux-Roels (UGent) , Edwige Haelterman, Cathy Maes, Jack Levy, Fien De Boever (UGent) , Laurent Licini, Marie-Pierre David, Kurt Dobbelaere and Dominique Descamps

(2011) CLINICAL AND VACCINE IMMUNOLOGY. 18(9). p.1510-1518

Academic Bibliography

Fien De Boever

Safety and immunogenicity of an adjuvanted clostridioides difficile vaccine candidate in healthy adults : a randomized placebo-controlled phase 1 study

Evaluation of safety, immunogenicity and cross-reactive immunity of OVX836, a nucleoprotein-based universal influenza vaccine, in older adults

Safety and immunogenicity of a carbohydrate fatty acid monosulphate ester adjuvant combined with a low-dose quadrivalent split-virion inactivated influenza vaccine : a randomised, observer-blind, active-controlled, first-in-human, phase 1 study

Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults : a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial

Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate : a randomised, double-blind, placebo-controlled, phase 2a trial

Randomized, double-blind, reference-controlled, phase 2a study evaluating the immunogenicity and safety of OVX836, a nucleoprotein-based influenza vaccine

A randomized, observer-blind phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women

Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults : a phase I/II randomized clinical study

Improved CD4⁺ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial

Randomized trial of the immunogenicity and safety of the hepatitis B vaccine given in an accelerated schedule coadministered with the human papillomavirus type 16/18AS04-adjuvanted cervical cancer vaccine

Contents

Support

Contact